Navigation Links
Halozyme Reports First Quarter 2013 Financial Results
Date:5/8/2013

SAN DIEGO, May 8, 2013 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today reported financial results for the quarter ended March 31, 2013.

(Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

"With the potential for 3 new product launches over the next 12 months and continued progress on the Hylenex® brand, I am pleased with the steps we are making towards our near term revenue drivers," said Gregory I. Frost , Ph.D., President and Chief Executive Officer, Halozyme. "Moreover, over the next 8 weeks, we will present a first-look at clinical data from our innovative pipeline products, PEGPH20 and HTI-501."

Highlights of Halozyme's first quarter activities and recent events include:

  • The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) granted a positive opinion to Baxter for the use of HyQvia as replacement therapy for adult patients with primary and secondary immunodeficiencies.
  • Initiated a 124 patient Phase 2 clinical study evaluating PEGPH20, a proprietary, investigational drug, as a first-line therapy for patients with stage IV metastatic pancreatic cancer. Patients in the study will receive gemcitabine and nab-paclitaxel either with or without PEGPH20. The primary endpoint will be to measure progression-free survival.
  • Initiated a 400 patient Phase 4 clinical study – The CONtinuous Subcutaneous Insulin infusion STudy ENrolling Type 1 Diabetes (CONSISTENT 1) – that will evaluate Hylenex use in conjunction with rapid analog insulin in people with Type 1 diabetes using insulin pumps. The primary endpoints include metabolic and safety outcomes.
  • Investigators at Yale
    '/>"/>

  • SOURCE Halozyme Therapeutics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Halozyme to Host First Quarter 2012 Financial Results Conference Call
    2. Halozyme Reports First Quarter 2012 Financial Results
    3. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
    4. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
    5. Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
    6. Halozyme Reports Second Quarter 2012 Financial Results
    7. Halozyme to Host Third Quarter Financial Results Conference Call
    8. Halozyme Therapeutics To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
    9. Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
    10. Halozyme Reports Fourth Quarter and Year End 2012 Financial Results
    11. Halozyme Therapeutics to Present at the Barclays 2013 Global Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... 2015  MedScope ( www.medscope.org ), the leading provider of ... Connected World magazine Connected World Award for ... can be used anywhere, anytime. The nomination was made ... In nominating MedScope, Landon Garner , Director of ...
    (Date:1/23/2015)... 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is ... Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... fiduciary duties to shareholders. On January 21, ... reporting that Advaxis had misrepresented the clinical data for ...
    (Date:1/23/2015)... 23, 2015  Now available for sale, The Armor1 Ankle ... prevents ankle sprains by cushioning the ankle from an ... around the outside of any shoe type and allows ... still offering protection against sprains. With customers in physical ...
    Breaking Medicine Technology:MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2
    ... Reportlinker.com announces that a new market research report is ... Pharmaceutical Packaging Market http://www.reportlinker.com/p0288103/US-Pharmaceutical-Packaging-Market.html ... 5.5% annually through 2014 Demand for ... increase 5.5 percent annually to $18.4 billion in 2014. ...
    ... Inc. (PSI), a leading pharmaceutical Contract Research Organization ... to help advance early stage molecules and drug ... Under the established framework between Children,s and PSI, ... at progressing the specific drug or drug product ...
    Cached Medicine Technology:Reportlinker Adds US Pharmaceutical Packaging Market 2Reportlinker Adds US Pharmaceutical Packaging Market 3Reportlinker Adds US Pharmaceutical Packaging Market 4Reportlinker Adds US Pharmaceutical Packaging Market 5Reportlinker Adds US Pharmaceutical Packaging Market 6Reportlinker Adds US Pharmaceutical Packaging Market 7Reportlinker Adds US Pharmaceutical Packaging Market 8Reportlinker Adds US Pharmaceutical Packaging Market 9Reportlinker Adds US Pharmaceutical Packaging Market 10Children's Hospital Boston and Particle Sciences Cooperate on Translational Medicine Efforts 2
    (Date:1/22/2015)... PA (PRWEB) January 22, 2015 Woodloch Pines, ... Mountains, has been selected by TripAdvisor as the number one ... the 6th best in the world for their annual Travelers’ ... online travel community . The website is home to millions ...
    (Date:1/22/2015)... The Incredible Bulk is a revolutionary method put ... muscle by up to 30lbs in less than 12 weeks ... Stan Stevenson, prompting an investigative review. , “Our Incredible ... diet formula that allows the body to pack on a ...
    (Date:1/22/2015)... New York (PRWEB) January 22, 2015 The ... ) in the U.S. District Court, Southern District of West ... Bard, Inc. in that proceeding’s first bellwether trial. In an ... for a new trial after finding that C.R. Bard had ...
    (Date:1/22/2015)... has released a new blog post explaining the main features ... , Auto insurance quotes help many drivers find the best ... call an agent or visit an agency for price information. ... http://autocarinsurancebest.com/ . , Every business who relies heavily on ...
    (Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 ... College of Sports Medicine flagship journal Medicine & ... with L-Citrulline before exercise may help reduce gastrointestinal ... exercise. 1 , Participants in the double-blind, ...
    Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
    ... a tattoo done of their lover's initials due to fear ... news - researchers have discovered a technique, where the cryptic ... wearer's choice. ,The new method is called micro-encapsulation, ... microcapsules, that are as tiny as pins, can bear a ...
    ... skin cancer many people still disregard the use of sunscreen to ... that one in three Briton do not protect their skin ... skin cancer are diagnosed in the UK each year, and recent ... in the next 30 years. ,Research by the ...
    ... on controlling immune system responses, announced the acquisition ... in organ transplantation. ,Circassia acquired the ... of Birmingham in the UK for an undisclosed ... on product sales. Scientifically, the ToleroTrans approach mirrors ...
    ... Hundreds of cyclists will be participating in the Memory Ride ... raising money to fight the disease that affects more ... in the 11th annual Memory Ride has a personal story ... family friend who has struggled with the disease. ...
    ... revolution this weekend when a fleet of 10,000 self-service bicycles hits ... metro for Parisians and tourists alike. ,As the Tour ... country, in Paris amateur cyclists will from Sunday be able to ... for short trips, dropping them off at any of 750 bike ...
    ... While the overall cost-effectiveness of Medicare benefits have been ... uninsured before receiving benefits at age 65 required ... been privately insured prior to receiving Medicare. These findings, ... the July 12 issue of the New England Journal ...
    Cached Medicine News:Health News:Sun Protection Ignored Despite Warnings 2Health News:Paris Set for Pedal Power Revolution 2Health News:Paris Set for Pedal Power Revolution 3Health News:Uninsured Adults Increase Medicare Costs 2Health News:Uninsured Adults Increase Medicare Costs 3
    ...
    ...
    ...
    Conforms to the convexity of the lens providing easier access to anterior capsule. Reduces pontential of corneal touch. 35G x 5/8in (.50 x 16mm)...
    Medicine Products: